106 related articles for article (PubMed ID: 27487624)
21. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
22. Benchmarking circumferential resection margin (R1) resection rate for rectal cancer in the neoadjuvant era.
Chambers W; Collins G; Warren B; Cunningham C; Mortensen N; Lindsey I
Colorectal Dis; 2010 Sep; 12(9):909-13. PubMed ID: 19508531
[TBL] [Abstract][Full Text] [Related]
23. [A case of locally advanced rectal cancer successfully treated by laparoscopic intersphincteric resection and effective neoadjuvant chemoradiation therapy].
Kanamoto A; Nakano T; Ojima E; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1974-7. PubMed ID: 24393984
[TBL] [Abstract][Full Text] [Related]
24. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
25. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
[TBL] [Abstract][Full Text] [Related]
26. Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
Sclafani F; Peckitt C; Cunningham D; Tait D; Giralt J; Glimelius B; Keränen SR; Bateman A; Hickish T; Tabernero J; Thomas J; Brown G; Oates J; Chau I
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):303-12. PubMed ID: 26031368
[TBL] [Abstract][Full Text] [Related]
27. [Preoperative radiochemotherapy of rectal carcinoma. Current status].
Rau B; Wust P; Riess H; Schlag PM
Zentralbl Chir; 2000; 125(4):356-64. PubMed ID: 10829316
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
[TBL] [Abstract][Full Text] [Related]
29. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
[TBL] [Abstract][Full Text] [Related]
30. The multidisciplinary approach to the treatment of rectal cancer: 2015 update.
Onyeuku NE; Ayala-Peacock DN; Russo SM; Blackstock AW
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):507-17. PubMed ID: 25431898
[TBL] [Abstract][Full Text] [Related]
31. Multivisceral resection for T4 or recurrent colorectal cancer.
Larkin JO; O'Connell PR
Dig Dis; 2012; 30 Suppl 2():96-101. PubMed ID: 23207940
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
[TBL] [Abstract][Full Text] [Related]
33. [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].
Murata K; Okamura S; Okubo H; Owada Y; Nishigaki T; Wada Y; Kato R; Makino S; Takeoka T; Okada K; Fukuchi N; Ebisui C; Kinuta M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2020-2. PubMed ID: 24393999
[TBL] [Abstract][Full Text] [Related]
34. Current neoadjuvant strategies in rectal cancer.
Julien LA; Thorson AG
J Surg Oncol; 2010 Mar; 101(4):321-6. PubMed ID: 20187066
[TBL] [Abstract][Full Text] [Related]
35. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer.
Glynne-Jones R; Mathur P; Elton C; Train ML
Best Pract Res Clin Gastroenterol; 2007; 21(6):1049-70. PubMed ID: 18070703
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
[TBL] [Abstract][Full Text] [Related]
37. Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer W; De Vries A; Öfner D; Rabl H; Koplmüller R; Greil R; Tschmelitsch J; Schmid R; Kapp K; Lukas P; Sedlmayer F; Höfler G; Gnant M; Thaler J;
Anticancer Res; 2014 Nov; 34(11):6767-73. PubMed ID: 25368289
[TBL] [Abstract][Full Text] [Related]
38. [What will determine the first-line treatment of a patient with rectal cancer?].
Lepistö A; Kouri M; Savolainen R; Ristimäki A
Duodecim; 2016; 132(12):1185-93. PubMed ID: 27483636
[TBL] [Abstract][Full Text] [Related]
39. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
[TBL] [Abstract][Full Text] [Related]
40. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
